IMTX
Immatics N.V.
NASDAQ · Healthcare · Biotechnology · DE
$9.56
+1.06%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 34.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.08x
- Price / sales
- 29.51x
- Price / cash flow
- -5.97x
Enterprise value
- Enterprise value
- $990.4M
- EV / sales
- 20.43x
- EV / EBITDA
- -4.40x
- EV / EBIT
- -3.76x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026